Clinical Trial Update: BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 study of BMS-247550 for advanced soft tissue sarcoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• BMS-247550

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma | Phase 2 | Status: TERMINATED